Philip Powell
Follow
Get notifications in MyBN when activity occurs.
Upgrade your subscription to use this feature.
Philip Powell
Non-Executive Director / Polynovo
Philip Powell has extensive experience in investment banking and specialises in capital raising, Initial Public Offerings, mergers and acquisitions, and other corporate finance assignments across a diverse range of sectors including utilities, IT, pharma, financial services, food and agriculture. He spent 10 years in senior financial roles at OAMPS, a former ASX-listed financial services group, and 10 years in audit with Arthur Andersen & Co in Melbourne, Sydney and Los Angeles.
Lists and Charts
Total Shareholder Return as at 31/03/21
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| th | Australian Leaders Fund | ||
| 214th | Noxopharm | 410% | |
| 732nd | CommsChoice Group | 120% | |
| 1014th | Polynovo | 69% | 57% |
| 1529th | Advance NanoTek | 8% | 72% |
1738 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Roles
Year started and most recent title
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 492nd |  | Polynovo | $22.2m |
| 506th | | Noxopharm | $19.9m |
| 507th | | Advance NanoTek | $19.9m |
| 509th | | Australian Leaders Fund | $0 |
| 510th | | CommsChoice Group | $19.3m |
1217 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Article Timeline
Person Activity
| NEW ROLE: Non-Executive Director, RMA Global | 03 Nov 2020 |
| REMUNERATION UPDATE: Non-Executive Director, Medical Developments International | 03 Nov 2020 |
| REMUNERATION UPDATE: Non-Executive Director, BARD1 Life Sciences | 02 Nov 2020 |
| NEW ROLE: Acting Managing Director, Polynovo | 09 Jul 2020 |
